OPK Biotech

OPK Biotech websites


	OPK Biotech acquires assets of Biopure Corporation - September 2009 OPK Biotech develops, manufactures, and brings to market innovative drugs in the class of oxygen therapeutics. Using proprietary technology, two products have been developed and manufactured: Hemopure^® (HBOC-201) [hemoglobin glutamer - 250 (bovine)] for human use, and Oxyglobin^® (HBOC-301) [hemoglobin glutamer - 200 (bovine)] for veterinary use. View Here


	A Resource Guide for individuals interested in the impact of OPK Biotech's Hemoglobin Based Oxygen Carriers (HBOCs) on laboratory assays. The information presented for Hemopure^® also applies to Oxyglobin^®. Learn More Hemopure^® has been used to treat surgical anemia in South Africa since 2001. Learn More Oxyglobin^® Animal Health More than 200,000 units have been sold in the United States and Europe. Learn More Latest News September 2009 OPK Biotech acquired the former Biopure Corporation, developer and manufacturer of two unique oxygen therapeutics, and all of its assets, including intellectual properties and facilities. Learn More

	©2009 OPK Biotech Legal Statement Terms of Use Privacy Policy Sitemap Contact Webmaster